Biomarcadores inflamatorios y de estrés oxidativo están asociados con la aparición de la enfermedad renal crónica en personas con obesidad y síndrome metabólico

by Professional Newco

Los resultados mostraron que, ya desde el inicio, quienes acabaron desarrollando ERC tenían niveles más altos de marcadores inflamatorios (IL-6, IL-1β o TNFα) y de daño oxidativo (malondialdehíd...

Read more

ARTHEx Biotech Upsizes Series B Financing Round to $87 millones

by ARTHEx Biotech

Proceeds to support further clinical development of lead program ATX-01 in Myotonic Dystrophy Type1, a unique therapy currently in Phase I-IIa, targeting miR23b

Read more

La importancia de contar con un certificado actualizado de Buena Práctica Clínica (BPC) ICH E6(R2)

by Sermes CRO

En el ámbito de la investigación clínica, la formación en Buenas Prácticas Clínicas (BPC) no es simplemente una formalidad: es un requisito esencial para garantizar la calidad, la ética y la le...

Read more

El Hospital Virgen Macarena emprende una investigación propia que contribuirá al diagnóstico y tratamiento precoz del Alzhéimer

by Hospital Universitario Virgen de la Macarena

La Unidad de Deterioro Cognitivo del centro hospitalario participa en tres ensayos clínicos y atiende a más de 3.500 pacientes cada año que padecen esta enfermedad neurodegenerativa

Read more

A new oral drug for obesity shows positive results in an international study with Vall d’Hebron participation

by Vall d’Hebron

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Read more

Cómo optimizar el reclutamiento de pacientes mediante una comunicación clínica clara y efectiva

by Sermes CRO

La comunicación clínica efectiva, por tanto, no es solo una herramienta operativa, sino un factor estratégico en la gestión de ensayos clínicos. Las CROs que integran enfoques centrados en el p...

Read more

Parc Taulí will evaluate a new therapy for Angelman syndrome

by Instituto de Investigación e Innovación Parc Taulí

The center is participating in an international clinical trial that seeks to improve patients' quality of life by addressing sleep, communication and motor disorders.

Read more

ORYZON to sponsor first Phelan-McDermid syndrome (PMS) burden of illness study

by Oryzon Genomics

Oryzon Genomics is proud to announce its participation as a sponsor of the first-ever Phelan-McDermid syndrome (PMS) burden of illness study. The study is led by CureShank, a research advocacy organiz...

Read more

2025: The Year AI Became Pharma’s Competitive Edge

by Rubió

Within two sprints, the same team shipped safer, faster work by changing who owned validation, where audit trails lived, and which KPIs unlocked budget — not by buying another model. You’ll leave ...

Read more

Elevating Clinical Development with Specialized Medical Services

by Pivotal

In the complex world of pharmaceutical and biotechnology drug development, PIVOTAL serves as your trusted medical partner – delivering expert medical oversight and strategic insight across every pha...

Read more

Synendos Therapeutics Reports Positive and Highly Promising Topline Results from Phase 1 Trials, Paving the Way for Phase 2 in Mental Health

by Ysios Capital

The studies established the lead asset SYT-510 to be well tolerated in healthy volunteers at all doses with a good safety profile

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream